Results 101 to 110 of about 5,967 (167)

Role of NTRK Fusion Genes in the Tumor Immune Microenvironment of HPV (+/-) Cervical Cancer. [PDF]

J Med Virol
Wang Q, Zhang C, Liu S, Li W, Wei W, Aziz AUR, Lu H, Wang D.   +7 more
europepmc   +1 more source

Impact of Long-Term Structured Exercise on Body Composition in an NTRK Fusion-Positive NSCLC Patient Treated With Entrectinib. [PDF]

Thorac Cancer
Avancini A, Sposito M, Adamoli G, Borsati A, Ciurnelli C, Scaglione IM, Eccher S, Toniolo L, Tregnago D, Longo L, Insolda J, Milella M, Schena F, Pilotto S, Belluomini L.   +14 more
europepmc   +1 more source

Generating in vitro models of NTRK-fusion mesenchymal neoplasia as tools for investigating kinase oncogenic activation and response to targeted therapy. [PDF]

Oncogenesis, 2023
Vanoli F, Herviou L, Tsuda Y, Sung P, Xie Z, Fishinevich E, Min SS, Mallen W, de Wardin HT, Zhang Y, Jasin M, Antonescu CR.   +11 more
europepmc   +1 more source

High-Grade Endometrial Stromal Sarcoma with <i>NTRK</i> Fusion and Response to Larotrectinib: A Case Report. [PDF]

J Clin Med
Bar-Noy T, Lozano-Franco R, Nagaria TS, Brodeur MN, Salvador S, Lau S.   +5 more
europepmc   +1 more source

Entrectinib for NTRK Fusion-Positive Metastatic Melanoma Progressing on Combined PD-1 and CTLA-4 Inhibition: A Case Report. [PDF]

Case Rep Oncol, 2023
Dawood S, Ali ZJ.
europepmc   +1 more source

Dissociation Between Tumor Response and PTTM Progression During Entrectinib Therapy in NTRK Fusion-Positive Colon Cancer. [PDF]

Curr Oncol
Nagano H, Ohyama S, Sato A, Igarashi J, Yamamoto T, Kobayashi M.   +5 more
europepmc   +1 more source

Correction: Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients with NTRK Fusion-Positive Solid Tumors. [PDF]

Clin Cancer Res, 2022
Demetri GD, De Braud F, Drilon A, Siena S, Patel MR, Cho BC, Liu SV, Ahn MJ, Chiu CH, Lin JJ, Goto K, Lee J, Bazhenova L, John T, Fakih M, Chawla SP, Dziadziuszko R, Seto T, Heinzmann S, Pitcher B, Chen D, Wilson TR, Rolfo C.   +22 more
europepmc   +1 more source

NTRK fusion positive colorectal cancer is a unique subset of CRC with high TMB and microsatellite instability. [PDF]

Cancer Med, 2022
Wang H, Li ZW, Ou Q, Wu X, Nagasaka M, Shao Y, Ou SI, Yang Y.   +7 more
europepmc   +1 more source

A Case of NTRK Fusion Corpus Sarcoma With Pseudobiphasic Growth Pattern and Literature Review. [PDF]

Int J Gynecol Pathol
Zhang XY, Jiang HW, Wen XB, Yu Q, Li Y, Wang H, Han J, Yang SC.   +7 more
europepmc   +1 more source

BPI-28592 as a novel second generation inhibitor for NTRK fusion tumors. [PDF]

NPJ Precis Oncol
Sheng J, Chen H, Fu B, Pan H, Wang J, Han W.   +5 more
europepmc   +1 more source